Sensodyne maker Haleon improves sales guidance after price hikes
The IndependentFor free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Toothpaste and painkiller maker Haleon has hiked its sales forecasts after revenues jumped more than a tenth in six months driven by price rises. Looking ahead, whilst we continue to expect a challenging environment given further pressure on consumer spending and global geopolitical and macroeconomic uncertainties, we remain confident in the resilience of Haleon's incredible portfolio of category leading brands Brian McNamara, Haleon Haleon highlighted strong performances by its Sensodyne, Paradontax, Panadol and Denture Care brands. “Looking ahead, whilst we continue to expect a challenging environment given further pressure on consumer spending and global geopolitical and macroeconomic uncertainties, we remain confident in the resilience of Haleon’s incredible portfolio of category leading brands.
Discover Related
